<DOC>
	<DOC>NCT00657995</DOC>
	<brief_summary>This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.</brief_summary>
	<brief_title>Tight Glycemic Control by Artificial Pancreas</brief_title>
	<detailed_description>This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease. weight loss greater than 10% during the previous 6 months signs of distant metastasis respiratory, renal,or heart disease Patients provided written informed consent prior to enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>pancreatogenic</keyword>
	<keyword>diabetes</keyword>
	<keyword>artificial</keyword>
	<keyword>pancreas</keyword>
</DOC>